Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANJU VASUDEVAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1043203888
CMS profile
1601
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$11,709.39

234 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,898.00 5
Food and Beverage $4,213.97 223
Education $597.42 6

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $2,936.02 9
SERVIER PHARMACEUTICALS LLC $1,775.28 2
E.R. Squibb & Sons, L.L.C. $1,260.63 12
Janssen Scientific Affairs, LLC $796.28 2
BeiGene USA, Inc. $546.67 2
Seagen Inc. $400.34 12
AstraZeneca Pharmaceuticals LP $346.39 15
Janssen Biotech, Inc. $314.52 16
Merck Sharp & Dohme LLC $270.07 14
Astellas Pharma US Inc $231.78 9
Novartis Pharmaceuticals Corporation $221.64 12
Lilly USA, LLC $205.49 5
Amgen Inc. $199.03 10
AVEO Pharmaceuticals, Inc. $184.16 6
Pharmacyclics LLC, an AbbVie Company $167.62 8
EISAI INC. $157.36 9
PFIZER INC. $132.29 7
Celgene Corporation $120.68 9
G1 Therapeutics, Inc. $114.47 6
Daiichi Sankyo Inc. $104.13 5
JAZZ PHARMACEUTICALS INC. $95.05 4
Genentech USA, Inc. $87.51 5
Gilead Sciences, Inc. $87.05 5
GENZYME CORPORATION $66.68 3
GlaxoSmithKline, LLC. $60.68 3
EMD Serono, Inc. $57.16 3
Heron Therapeutics, Inc. $51.08 4
Pharmacosmos Therapeutics Inc. $49.33 2
TG Therapeutics, Inc. $45.78 2
Rigel Pharmaceuticals, Inc. $44.10 2
Karyopharm Therapeutics Inc. $43.03 2
Sobi, Inc $38.43 2
Regeneron Healthcare Solutions, Inc. $37.87 2
Kite Pharma, Inc. $32.57 1
Boehringer Ingelheim Pharmaceuticals, Inc. $28.38 1
Alexion Pharmaceuticals, Inc. $25.20 1
Myriad Genetic Laboratories, Inc. $24.25 1
EUSA Pharma (US) LLC $24.18 1
Deciphera Pharmaceuticals Inc. $23.57 1
Medtronic, Inc. $19.58 1
Taiho Oncology, Inc. $19.15 1
Takeda Pharmaceuticals U.S.A., Inc. $19.12 1
Adaptive Biotechnologies Corporation $18.30 1
Global Blood Therapeutics, Inc. $18.20 1
MorphoSys, US Inc. $18.19 1
GE HealthCare $17.77 1
Emmaus Medical, Inc. $17.12 1
ARRAY BIOPHARMA INC $16.97 1
PUMA BIOTECHNOLOGY, INC. $15.28 1
Octapharma USA, Inc. $14.99 1
Alnylam Pharmaceuticals Inc. $14.95 1
Apellis Pharmaceuticals, Inc. $13.87 1
Acrotech Biopharma LLC $13.80 1
Blueprint Medicines Corporation $13.51 1
Kyowa Kirin, Inc. $13.31 1
Epizyme, Inc., $13.07 1
Ipsen Biopharmaceuticals, Inc $13.02 1
Bayer HealthCare Pharmaceuticals Inc. $12.44 1

Page 2 of 5; records 51–100 of 234 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANJU VASUDEVAN

NPI 1043203888 · CMS profile ID 1601

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 234 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043203888?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 234 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043203888?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 234 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043203888?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 234 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1043203888?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

234 matching records · $11,709.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 234 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 234.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Rigel Pharmaceuticals, Inc. $28.0310/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962281259 CMS
Merck Sharp & Dohme LLC $14.6210/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944227401 CMS
AstraZeneca Pharmaceuticals LP $18.4909/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915256039 CMS
E.R. Squibb & Sons, L.L.C. $20.4509/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955931 CMS
Novartis Pharmaceuticals Corporation $16.6809/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894433049 CMS
Myriad Genetic Laboratories, Inc. $24.2509/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937241169 CMS
Blueprint Medicines Corporation $13.5109/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958935003 CMS
ARRAY BIOPHARMA INC $16.9709/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949232993 CMS
Seagen Inc. $99.9909/19/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904115725 CMS
Celgene Corporation $11.5409/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955947 CMS
PFIZER INC. $18.0809/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949329367 CMS
EMD Serono, Inc. $19.7109/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941559577 CMS
E.R. Squibb & Sons, L.L.C. $44.5209/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955923 CMS
PFIZER INC. $17.6609/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949347269 CMS
JAZZ PHARMACEUTICALS INC. $24.6109/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951329195 CMS
Seagen Inc. $16.2008/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904115707 CMS
AstraZeneca Pharmaceuticals LP $74.9908/30/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915490585 CMS
EISAI INC. $14.4408/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908017925 CMS
EISAI INC. $20.1208/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908017921 CMS
Seagen Inc. $23.0308/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904115691 CMS
Amgen Inc. $16.2908/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939904075 CMS
G1 Therapeutics, Inc. $18.2808/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954040107 CMS
MorphoSys, US Inc. $18.1908/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962539177 CMS
Daiichi Sankyo Inc. $20.7008/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930817851 CMS
Janssen Biotech, Inc. $14.7408/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885715375 CMS
Janssen Biotech, Inc. $19.8108/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885715381 CMS
Astellas Pharma US Inc $14.9408/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940253711 CMS
Gilead Sciences, Inc. $15.7408/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929581825 CMS
Pharmacyclics LLC, an AbbVie Company $19.5408/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890349217 CMS
GENZYME CORPORATION $28.5608/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938788583 CMS
AstraZeneca Pharmaceuticals LP $18.0208/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915865493 CMS
G1 Therapeutics, Inc. $18.7808/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954040111 CMS
Alnylam Pharmaceuticals Inc. $14.9508/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 926071133 CMS
AstraZeneca Pharmaceuticals LP $22.7108/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914824425 CMS
Lilly USA, LLC $18.2208/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917875691 CMS
GlaxoSmithKline, LLC. $20.7708/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944693965 CMS
Janssen Scientific Affairs, LLC $38.7808/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887199051 CMS
Merck Sharp & Dohme LLC $15.8308/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944206025 CMS
Celgene Corporation $24.6908/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955921 CMS
Merck Sharp & Dohme LLC $23.1807/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944354829 CMS
GlaxoSmithKline, LLC. $17.7307/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944693969 CMS
Merck Sharp & Dohme LLC $22.3007/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944191903 CMS
Genentech USA, Inc. $17.5707/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950709171 CMS
Celgene Corporation $14.0607/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955903 CMS
Novartis Pharmaceuticals Corporation $14.3307/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894433047 CMS
Lilly USA, LLC $122.5107/18/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917870805 CMS
Amgen Inc. $20.8807/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939904085 CMS
Celgene Corporation $21.8207/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955901 CMS
Pharmacosmos Therapeutics Inc. $24.5407/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959147939 CMS
Celgene Corporation $8.7707/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932955913 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $7,334.59 196
PY2020 $11,730.82 169
PY2021 $8,641.90 207
PY2022 $11,709.39 234
PY2023 $8,827.27 216
PY2024 $5,563.29 224
PY2025 $10,729.10 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $615,355.98 6
PY2024 Principal investigator $65,007.80 9
PY2023 Principal investigator $101,468.00 33
PY2022 Principal investigator $71,026.00 44
PY2021 Principal investigator $9,181.40 5
PY2020 Recipient $139.20 1
PY2020 Principal investigator $24,956.00 4
PY2019 Recipient $1,925.67 2
PY2019 Principal investigator $36,438.65 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $80.86 11/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312333
Principal investigator 1 Novartis Pharmaceuticals Corporation $121,062.48 09/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312335
Principal investigator 1 ABBVIE INC. $40,884.36 05/14/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484835
Principal investigator 1 ABBVIE INC. $9,045.00 05/13/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484735
Principal investigator 1 ABBVIE INC. $5,000.00 05/07/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202483379
Principal investigator 1 Novartis Pharmaceuticals Corporation $439,283.28 04/16/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312337

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2022 Amount invested $0.00 1
PY2022 Value of interest $119,000.00 1
PY2021 Amount invested $0.00 1
PY2021 Value of interest $92,200.00 1
PY2020 Amount invested $0.00 1
PY2020 Value of interest $90,000.00 1
PY2019 Amount invested $0.00 1
PY2019 Value of interest $135,000.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

4 records · PY2019–2022

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2022 Innovation Technologies Inc $0.00 $119,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 954225435
PY2021 Innovation Technologies Inc $0.00 $92,200.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 849647691
PY2020 Innovation Technologies Inc $0.00 $90,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 749849307
PY2019 Innovation Technologies Inc $0.00 $135,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 694466579